// App-Quantinova.ai

2918 : Interaction between MUC1 and STAT1 drives IFITM1 overexpression in aromatase inhibitor-resistant breast cancer cells

Researchers

Presenter

  • Asona Lui

Principal Investigators

  • Joan Lewis-Wambi

Medical Centers

  • University of Kansas Medical Center, Kansas City, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Kerbs von Lungren 6 antigen

  • Annexin V

  • Aromatase

  • Interferon-induced transmembrane protein 1

  • Janus kinase

  • Signal Transducer And Activator Of Transcription 1

Drug/Treatment

  • Fulvestrant

  • Ruxolitinib phosphate

  • Interferon

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved